One patient, two lesions, two oncogenic drivers of gastric cancer

Genome Biol. 2014 Aug 27;15(8):444. doi: 10.1186/s13059-014-0444-9.

Abstract

Deep-sequencing of a primary tumor and metastasis from a single patient, and functional validation in culture, reveals that TGFBR2 and FGFR2 act as drivers of gastric cancer.

Publication types

  • Introductory Journal Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disease Progression
  • Gene Amplification
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Neoplasm Metastasis
  • Protein Serine-Threonine Kinases / genetics*
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics*
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta / genetics*
  • Sequence Analysis, DNA / methods*
  • Sequence Deletion
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • Receptors, Transforming Growth Factor beta
  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II